I agree, rising. The "positive" issue is that they seem to take...

I agree, rising. The "positive" issue is that they seem to take measurements at least every 3 months. So in the open, biometric study, we may get early results as soon as some 7-8 patients have taken ATH434 for 3 -6 months (??). This is only if the company is willing to tell these results, i.e. if the results are positive. But IMO they have the early results pretty soon. Looks like they will recruit 2 patients per month so they have now perhaps 7 patients taking ATH434, the first ones already for 3 months.

The main interim outcome measures will be UMSARS, NNIPPS, NFL, and alpha-synuclein during the study, and perhaps MRI only after 12 months. These new measures in the presented poster are too new at this time.